Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RTN4RL1 antisense RNA 2 (RTN4RL1-AS2)
- Target
- RTN4RL1-AS2
- Molecular classification
- Long non-coding RNA (lncRNA), antisense RNA
01
Overview
RTN4RL1 antisense RNA 2 (RTN4RL1-AS2) is a long non-coding antisense RNA transcribed from the RTN4RL1 locus. Antisense RNAs are non-protein-coding transcripts that can interact with their corresponding sense mRNAs or gene regulatory regions to modulate gene expression[3]. Depending on their sequence complementarity and cellular context, antisense lncRNAs can act in cis or trans to regulate transcription, translation, chromatin organization, and potentially participate in disease processes, notably cancer and developmental disorders[3]. There is currently no direct evidence in major databases or literature that RTN4RL1-AS2 itself is a therapeutic target, receptor, or has a defined disease role.
- Other names
- RTN4RL1-AS2Reticulon 4 receptor like 1 antisense RNA 2
02
Biological functions
Regulation of gene expression (general function of antisense RNAs)Possible involvement in transcriptional interference and modulation of chromatin state
03
Disease associations
Potential involvement in cancer or disease via regulation of gene expression, analogously to other antisense lncRNAs, but no direct evidence for RTN4RL1-AS2 specifically
04
Safety considerations
no direct safety concerns; therapeutic modulation of antisense RNAs has general challenges, such as off-target effects, but nothing specific for RTN4RL1-AS2
Beyond the preview
Go deeper on RTN4RL1 antisense RNA 2 (RTN4RL1-AS2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RTN4RL1 antisense RNA 2 (RTN4RL1-AS2).